Pathology News Roundup: August 2025

Visit with Voicebrook at CAP25. Are you heading to Orlando for CAP25? Voicebrook would love to see you there!

The CAP's annual meeting kicks off on September 13, leveraging the collective knowledge of member experts with comprehensive, relevant CME courses; round table discussions; and networking events.

Visit Booth 316 for Voicebrook demos & exclusive giveaways. Our team will be onsite and they're excited to meet with you. Spots for live demos at CAP25 may be limited, so advance booking is recommended. 

See you in Orlando!

Tariff Exemption Needed for Lab Supplies. The College of American Pathologists is urging the Department of Commerce to exempt medical devices and lab supplies from tariffs to ensure continued access to essential diagnostic materials. In a letter to Howard Lutnick, Secretary of the U.S. Department of Commerce, the CAP expressed the need for affordable diagnostic products, including test kits and pipette tips, which are crucial for accurate and timely patient care.

Tariffs on these products increase costs, which affects clinical testing, particularly in rural and medically underserved areas, the CAP said. Tariffs also pose the risk of decreasing innovation and limiting testing capabilities, which could significantly influence public health. Without exemptions, growing financial pressures on health care providers will limit access to necessary testing and innovation.

Push to Save Cancer Surveillance. Congress is finalizing budget decisions that could impact the future of cancer surveillance on a national scale. A 2026 budget plan proposes eliminating the CDC’s Division of Cancer Prevention and Control. This program funds and coordinates cancer surveillance nationwide. Removing the division would undermine data collection, screening, and prevention, and could pause other cancer-related programs.

In 2026, over two million new cancer diagnoses are expected in the US. Ongoing support is critical to advance cancer prevention and treatment efforts.

You can let federal lawmakers know how this affects your patients and your lab.